Praxis Medical Insights

Diagnosis and Initial Management

The European Urology guideline recommends obtaining urine culture and susceptibility testing before initiating antimicrobial therapy due to the wide spectrum of potential infecting organisms and increased likelihood of antimicrobial resistance 1, 2
For patients with a catheter in place for ≥2 weeks at the onset of UTI, the guideline suggests replacing it before starting antibiotics to hasten symptom resolution and reduce the risk of subsequent infection 1, 3
Signs and symptoms compatible with CAUTI include new onset or worsening of fever, rigor, altered mental status, malaise, flank pain, costovertebral angle tenderness, acute hematuria, pelvic discomfort, and in patients whose catheter has been removed: dysuria, urgency, frequency, and suprapubic pain 4

The guideline strongly recommends intravenous third-generation cephalosporin as first-line empirical treatment 1
Alternative first-line options include amoxicillin plus an aminoglycoside 1 and second-generation cephalosporin plus an aminoglycoside 1

The guideline recommends 7 days of antimicrobial therapy for patients who show prompt clinical response 1, 2
For patients with delayed response, the guideline suggests 10-14 days of antimicrobial therapy 1, 2
For male patients where prostatitis cannot be excluded, the guideline recommends 14 days of antimicrobial therapy 4, 2

CAUTIs have a broader microbial spectrum than uncomplicated UTIs, with common pathogens including E. coli, Proteus spp., Klebsiella spp., Pseudomonas spp., Serratia spp., and Enterococcus spp. 4, 1
For S. aureus CAUTI, the guideline recommends removing the catheter immediately and treating with appropriate antibiotics for 4-6 weeks unless specific exceptions apply 5
For coagulase-negative staphylococci, the guideline suggests removing the catheter and treating with appropriate antibiotics 5

Fluoroquinolones can be used only if local resistance rates are <10%, the patient has not used fluoroquinolones in the last 6 months, the patient does not require hospitalization, and the patient has anaphylaxis to β-lactam antimicrobials 4, 1

The guideline recommends removing or replacing the catheter before starting antibiotic therapy whenever possible 1, 3
For patients with urinary retention and UTI, the guideline suggests ensuring appropriate antibiotic treatment before removing the Foley catheter 3

The guideline advises against using fluoroquinolones for empirical treatment in patients from urology departments or when patients have used fluoroquinolones in the last 6 months due to increased risk of resistance 4, 1
The guideline recommends avoiding treatment of asymptomatic bacteriuria in catheterized patients unless specific indications exist 1
CAUTIs are the leading cause of secondary healthcare-associated bacteremia, with approximately 20% of hospital-acquired bacteremias arising from the urinary tract and a mortality rate of approximately 10% 4

The guideline recommends monitoring for resolution of symptoms, such as fever, dysuria, and flank pain 2
The guideline suggests considering complications or resistant organisms if symptoms persist beyond 48 hours of appropriate therapy 2
The guideline recommends monitoring for signs of UTI recurrence after catheter removal 3